The EDAR Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population in which the EDAR gene has been disrupted using a pooled editing strategy, resulting in a heterogeneous population of EDAR-deficient HAP1 cells. This product provides a powerful loss-of-function model for investigating ectodysplasin A (EDA) receptor signaling, NF-??B pathway activation, and downstream developmental processes associated with ectodermal appendage formation.
The host cell line, HAP1, is a near-haploid human cell line originally derived from the KBM-7 chronic myeloid leukemia line. Its haploid karyotype facilitates biallelic gene disruption with a single targeting event and enables efficient haploid genetic screens, making it an ideal platform for creating knockout models. HAP1 cells retain many characteristics of somatic cells and are widely used for functional genomics, drug target identification, and pathway dissection.
EDAR encodes a member of the tumor necrosis factor receptor superfamily that serves as the receptor for ectodysplasin A (EDA). Ligand binding promotes receptor trimerization and recruitment of the adaptor protein EDARADD, which in turn interacts with TRAF6, TAB2, and the IKK complex to activate the canonical NF-??B pathway. This signaling cascade culminates in the phosphorylation and degradation of I??B?? (NFKBIA), releasing NF-??B transcription factors such as RELA and NFKB1 to translocate to the nucleus. EDAR/NF-??B activity transcriptionally regulates genes critical for ectodermal development, including WNT10A, WNT10B, and DKK4, establishing a link between ectodysplasin signaling and Wnt pathway modulation.
Disruption of EDAR in HAP1 cells abrogates EDA-mediated NF-??B activation, effectively recapitulating the signaling defects observed in hypohidrotic ectodermal dysplasia. The polyclonal nature of this knockout population provides an aggregate view of loss-of-function phenotypes, making it suitable for population-level assays and high-throughput screening. In the haploid background, this model enables straightforward genetic manipulation and complementation studies to dissect EDAR-dependent and -independent pathways.
This knockout model is applicable to a variety of experimental workflows, including western blotting to confirm loss of EDAR protein, RT-qPCR quantification of downstream targets such as WNT10A and RELA, and NF-??B luciferase reporter assays following EDA stimulation. The cells are also suited for phospho-I??B?? analysis, co-immunoprecipitation of EDARADD complexes, and high-content screening for small molecules that modulate ectodysplasin signaling. Researchers can employ this tool to investigate epithelial-mesenchymal interactions, tooth agenesis, and other ectodermal dysplasia-related phenotypes. For further technical details or to discuss custom applications, please contact Ascent Research.
